Malignant glioma subset from actuate 1801: Phase I/II study of 9-ING-41, GSK-3β inhibitor, monotherapy or combined with chemotherapy for refractory malignancies

BACKGROUND: GSK3β serine/threonine kinase regulates metabolism and glycogen biosynthesis. GSK3β overexpression promotes progression and resistance through NF-κB and p53 apoptotic pathways. GSK3β inhibits immunomodulation by downregulating PD-L1 and LAG-3 checkpoints and increasing NK and T-cell tumo...

Descripción completa

Detalles Bibliográficos
Autores principales: Odia, Yazmin, Cavalcante, Ludimila, Safran, Howard, Powell, Steven Francis, Munster, Pamela N, Ma, Wen Wee, Carneiro, Benedito A, Bastos, Bruno R, Mikrut, Stacy, Mikrut, William, Giles, Francis J, Sahebjam, Solmaz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Clinical Investigations
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8989389/
https://www.ncbi.nlm.nih.gov/pubmed/35402914
http://dx.doi.org/10.1093/noajnl/vdac012

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8989389/
https://www.ncbi.nlm.nih.gov/pubmed/35402914
http://dx.doi.org/10.1093/noajnl/vdac012

Ejemplares similares